Background on Arrayit’s CEO, Rene Schena, Chosen to Promote Economic Growth Center to Big Pharma and Biotech Businesses

FOR IMMEDIATE RELEASE
Sunnyvale, California, United States of America (Free-Press-Release.com) December 4, 2011 --

(Updated February 2, 2012) Rene Schena formed Arrayit Corporation from the Biotech Division of TeleChem International Inc., a company she established in 1993. Her management has lead Arrayit to a leadership position in microarray technology with instrumentation, patented device and streaming consumable placements worldwide. She is recognized by the business community as a leader and her company has received acclamations and awards from various organizations including the DLA - Defense Logistics Agency for "quality, price and on time delivery". Ms. Schena’s strong business background, management expertise and determination have resulted in Arrayit's current publicly traded status (ARYC) with strong patent and intellectual property positions and a solid customer base.

Ms. Schena holds a degree in Language Studies from the University of California, Santa Cruz. She has 26 years experience in international business, including translation, contract documentation and commodities trading. She worked in commodities trading with a subsidiary of ConAgra (1985-1988) and as a chemical import and distribution specialist, department manager, and later President of NuSource Chemical Corporation (1988-1993). Ms. Schena founded TeleChem International, Inc., continuing the import and export chemical distribution specialty, expanded into government-bid business, and expanded again into the biotech sector in 1996. Her management skills, long-term contacts, strong business background and knowledge of supply-chain distribution were key contributions to TeleChem and the growth of the microarray business and Arrayit. Ms. Schena manages all corporate financial, tax, legal, regulatory and human resources activities, including budgeting, tax-related activities, investments, loans, financial strategies, major contract negotiations, patent and litigation activities, legal strategies, payroll, employee reviews, benefits, insurance, claims, inventory control, corporate administrative management, regulatory compliance, regulatory reporting and agency interface.

About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. Please visit www.arrayit.com for more information.

Safe Harbor Statement

We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-KA for the fiscal year ended December 31, 2010 and Form 10-QA for the fiscal quarter ended September 30, 2011.

Arrayit     Arrayit Corporation CEO Schena     Biotech     Biotech Cluster     diagnostics     gene     microarray     Rene Schena